UK markets closed

PTC Therapeutics, Inc. (PTCT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.20-0.00 (-0.02%)
As of 12:56PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-626,604
-626,604
-559,017
-523,901
-438,160
Depreciation & amortisation
236,590
236,590
128,836
64,134
43,490
Deferred income taxes
-46,930
-46,930
-34,276
377
5,872
Stock-based compensation
131,206
131,206
110,333
103,513
70,325
Change in working capital
-4,003
-4,003
-85,335
-23,788
36,911
Accounts receivable
-1,539
-1,539
-48,468
-44,991
-10,483
Inventory
-8,183
-8,183
-6,668
1,800
1,841
Other working capital
-279,037
-279,037
-509,114
-336,663
-250,048
Other non-cash items
-104,670
-104,670
186
62,957
177,608
Net cash provided by operating activities
-158,418
-158,418
-356,654
-251,332
-194,071
Cash flows from investing activities
Investments in property, plant and equipment
-120,619
-120,619
-152,460
-85,331
-55,977
Purchases of investments
-212,484
-212,484
-75,551
-543,266
-1,449,665
Sales/maturities of investments
156,366
156,366
518,192
847,779
944,094
Net cash used for investing activities
-176,737
-176,737
290,181
219,182
-561,548
Cash flows from financing activities
Debt repayment
-301,379
-301,379
-151,276
-2,224
-46,162
Common stock issued
0
0
50,000
0
28,092
Other financing activities
917,785
917,785
-51,854
-
611,303
Net cash used provided by (used for) financing activities
646,400
646,400
167,952
20,877
668,715
Net change in cash
314,359
314,359
98,707
-19,094
-79,216
Cash at beginning of period
295,925
295,925
197,218
216,312
295,528
Cash at end of period
610,284
610,284
295,925
197,218
216,312
Free cash flow
Operating cash flow
-158,418
-158,418
-356,654
-251,332
-194,071
Capital expenditure
-120,619
-120,619
-152,460
-85,331
-55,977
Free cash flow
-279,037
-279,037
-509,114
-336,663
-250,048